Purdue Institute for Drug Discovery

LT75

Overview: 

PSMA-targeted DNA repair inhibitors for the treatment of prostate cancer

Status: 

Purdue Faculty: 

Dr. Madduri Srinivasarao

Dr. Phil Low

Development Partner: 

Low Institute for Therapeutics